Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review

Immune checkpoint inhibitors (ICIs), immunomodulatory antibodies that are used to enhance the immune system, have substantially improved the prognosis of patients with advanced malignancy. As the use of ICI therapy becomes increasingly widespread across different types of cancer, their use in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitchlu, Abhijat, Jhaveri, Kenar D, Sprangers, Ben, Yanagita, Motoko, Wanchoo, Rimda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Ckj Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406068/
https://www.ncbi.nlm.nih.gov/pubmed/34476087
http://dx.doi.org/10.1093/ckj/sfab090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406068/
https://www.ncbi.nlm.nih.gov/pubmed/34476087
http://dx.doi.org/10.1093/ckj/sfab090

Ejemplares similares